Join
Live feed
·
INSIDERFilingvia Quantisnow
Synaptogenix Inc. logo

SEC Form 4: Alkon Daniel L. was granted 43,750 shares, increasing direct ownership by 381% to 55,234 units (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.
SNPX· Synaptogenix Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNPX (Synaptogenix Inc.) and more on Quantisnow.